Drug or treatment
Mitazalimab clinical trials
As of November 12, 2026, Find a Trial lists 2 clinical trials of Mitazalimab that are recruiting, in United States. By phase: Early Phase 1 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Pre-surgery intratumoral mitazalimab for resectable breast cancer
This test gives a single intratumoral dose of mitazalimab, with or without nivolumab, to adults with resectable stage I–III breast cancer at least 7 days before their planned surgery.
-
Using a CD40 antibody with electroporation to treat advanced pancreatic cancer
This study is testing a new way to treat advanced pancreatic cancer by injecting a special antibody directly into tumors during surgery to see if it helps the immune system fight the cancer better.
Quick answers
How many clinical trials of Mitazalimab are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.